- cafead   Mar 11, 2024 at 05:12: PM
via Acadia Pharmaceuticals (ACAD.O) said on Monday its antipsychotic drug failed to significantly improve negative symptoms of schizophrenia, including poor socialization and lack of motivation, in a late-stage study.
article source
article source